ReviewBritish journal of cancer2020

Integrating DNA methylation measures to improve clinical risk assessment: are we there yet? The case of BRCA1 methylation marks to improve clinical risk assessment of breast cancer.

Ee Ming Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.